Lucid Diagnostics Inc
NASDAQ:LUCD
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.7625
1.65
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one LUCD stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.14 USD, Lucid Diagnostics Inc is hidden .
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Lucid Diagnostics Inc
LUCD looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether LUCD usually does or if today's premium is unusual.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Lucid Diagnostics Inc.
| US |
|
Abbott Laboratories
NYSE:ABT
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
|
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Lucid Diagnostics Inc
Balance Sheet Decomposition
Lucid Diagnostics Inc
| Current Assets | 49.8m |
| Cash & Short-Term Investments | 47.3m |
| Receivables | 550k |
| Other Current Assets | 2m |
| Non-Current Assets | 3.4m |
| PP&E | 2.9m |
| Intangibles | 421k |
| Other Non-Current Assets | 52k |
| Current Liabilities | 26.2m |
| Accounts Payable | 751k |
| Accrued Liabilities | 3.2m |
| Short-Term Debt | 22.3m |
| Non-Current Liabilities | 1.2m |
| Other Non-Current Liabilities | 1.2m |
Free Cash Flow Analysis
Lucid Diagnostics Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Lucid Diagnostics Inc
|
Revenue
|
4.4m
USD
|
|
Cost of Revenue
|
-7m
USD
|
|
Gross Profit
|
-2.6m
USD
|
|
Operating Expenses
|
-45.4m
USD
|
|
Operating Income
|
-48m
USD
|
|
Other Expenses
|
-17.8m
USD
|
|
Net Income
|
-65.8m
USD
|
LUCD Profitability Score
Profitability Due Diligence
Lucid Diagnostics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Lucid Diagnostics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.
LUCD Solvency Score
Solvency Due Diligence
Lucid Diagnostics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Lucid Diagnostics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LUCD Price Targets Summary
Lucid Diagnostics Inc
According to Wall Street analysts, the average 1-year price target for LUCD is 3.83 USD with a low forecast of 2.53 USD and a high forecast of 8.4 USD.
Dividends
Current shareholder yield for LUCD is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one LUCD stock under the Base Case scenario is hidden USD.
Compared to the current market price of 1.14 USD, Lucid Diagnostics Inc is hidden .